Original language | English (US) |
---|---|
Pages (from-to) | 89-92 |
Number of pages | 4 |
Journal | JAAD Case Reports |
Volume | 22 |
DOIs | |
State | Published - Apr 2022 |
Funding
Funding sources: None.
Keywords
- LCV
- avapritinib
- cutaneous adverse event
- imatinib
- leukocytoclastic vasculitis
- oncology
- prednisone taper
- purpura
- rash
- receptor tyrosine kinase
- targeted therapy
ASJC Scopus subject areas
- Dermatology